These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19767691)

  • 1. Implant treatment in patients with osteoporosis.
    Mellado-Valero A; Ferrer-García JC; Calvo-Catalá J; Labaig-Rueda C
    Med Oral Patol Oral Cir Bucal; 2010 Jan; 15(1):e52-7. PubMed ID: 19767691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
    Famili P; Quigley S; Mosher T
    Compend Contin Educ Dent; 2011; 32(6):E106-9. PubMed ID: 23738968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates and dental implants: current problems.
    Flichy-Fernández AJ; Balaguer-Martínez J; Peñarrocha-Diago M; Bagán JV
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E355-60. PubMed ID: 19561566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
    Madrid C; Sanz M
    Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series.
    Goss A; Bartold M; Sambrook P; Hawker P
    J Oral Maxillofac Surg; 2010 Feb; 68(2):337-43. PubMed ID: 20116705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General and oral aspects of osteoporosis: a review.
    von Wowern N
    Clin Oral Investig; 2001 Jun; 5(2):71-82. PubMed ID: 11480813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
    Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
    Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy.
    Mozzati M; Arata V; Giacomello M; Del Fabbro M; Gallesio G; Mortellaro C; Bergamasco L
    J Craniofac Surg; 2015 May; 26(3):749-55. PubMed ID: 25974785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review.
    Chadha GK; Ahmadieh A; Kumar S; Sedghizadeh PP
    J Oral Implantol; 2013 Aug; 39(4):510-20. PubMed ID: 23964780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implant placement in patients with oral bisphosphonate therapy: a case series.
    Shabestari GO; Shayesteh YS; Khojasteh A; Alikhasi M; Moslemi N; Aminian A; Masaeli R; Eslami B; Treister NS
    Clin Implant Dent Relat Res; 2010 Sep; 12(3):175-80. PubMed ID: 19438964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and osteonecrosis of the jaw.
    Sambrook P; Olver I; Goss A
    Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
    Kurth AH; Eberhardt C; Müller S; Steinacker M; Schwarz M; Bauss F
    Bone; 2005 Aug; 37(2):204-10. PubMed ID: 15936997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review.
    Javed F; Almas K
    J Periodontol; 2010 Apr; 81(4):479-84. PubMed ID: 20367090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw after oral bisphosphonate for osteoporosis.
    Tong CK; Ho ST; Wong SL
    Hong Kong Med J; 2010 Apr; 16(2):145-8. PubMed ID: 20354251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental implants in patients treated with oral bisphosphonates: a bibliographic review.
    Montoya-Carralero JM; Parra-Mino P; Ramírez-Fernández P; Morata-Murcia IM; Mompeán-Gambín Mdel C; Calvo-Guirado JL
    Med Oral Patol Oral Cir Bucal; 2010 Jan; 15(1):e65-9. PubMed ID: 19767707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of age, jaw site, and bone condition on oral implant outcomes.
    Bryant SR
    Int J Prosthodont; 1998; 11(5):470-90. PubMed ID: 9922739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety considerations with bisphosphonates for the treatment of osteoporosis.
    Strampel W; Emkey R; Civitelli R
    Drug Saf; 2007; 30(9):755-63. PubMed ID: 17722968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.